evipedia.ai
← Back

Lavender Oil for Health & Longevity

Created on 10/23/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Lavender oil, a plant oil inhaled, applied to skin, or administered orally as a standardized capsule, is used for anxiety, sleep and stress. The capsule shows a modest calming effect over several weeks; inhaled oil calms short-term, though some studies found no benefit. Better sleep, less fatigue and brief pain relief are supported. Drawbacks are mostly mild. Almost all capsule research was manufacturer-funded; retail oils vary widely. (Full Review)

Protocol

Oral standardized oil (anxiety, low mood)
Silexan 80 mg once daily
For 6–10 weeks, the regimen of the placebo-controlled trials; guideline range 80–160 mg/day
Inhaled aromatherapy (procedures, acute stress)
One to several drops (20–120 mg)
On a cotton pad, inhaled shortly before surgery or procedures
Inhaled aromatherapy (sleep)
2% lavender oil inhaled nightly
For 15 days in one trial; or 3 mL of pure oil in a jar at the bedside overnight
Time to effect
Anxiety (oral capsule)
About 2 weeks
Seen in a capsule trial
Calming (inhaled)
Within minutes
Inhaled effects are short-lived
Sleep (oral capsule)
About 6 weeks
Oral sleep gains depend on anxiety relief

Benefits

Contraindications
  • Known allergy to lavender oil, oxidized linalool or fragrance mixes
  • Children under 12 years (medicinal lavender oil products)
  • Prepubertal children (repeated topical exposure)
  • Pregnant and breastfeeding women (oral use)
  • Open wounds, skin disease, high fever, severe infection or severe heart and circulation problems (full lavender-oil baths)
    •
Key Interactions
  • Benzodiazepines, Z-drugs and opioids (lorazepam, oxycodone): Caution (theoretical): additive drowsiness with inhaled or high-dose use
  • General anesthetics (propofol): Caution: inadequate intravenous anesthesia with long-term Silexan use (one case report)
  • CYP-cleared drugs (midazolam, omeprazole): No relevant interaction with Silexan 160 mg/day; generic oil: monitor (theoretical) for raised levels
  • Combined oral contraceptives (ethinyl estradiol with levonorgestrel): No interaction; could theoretically weaken time-critical emergency contraception
  • Antihypertensives (amlodipine, metoprolol): Monitor (theoretical): additive blood pressure lowering with inhaled lavender, lightheadedness
  • Anticoagulants and antiplatelets (warfarin, aspirin): Caution (theoretical): possibly adding to bleeding risk
  • Serotonergic antidepressants (sertraline): Monitor (theoretical): no serotonin toxicity reported
  • Sedating over-the-counter antihistamines and alcohol (diphenhydramine): Caution (theoretical): additive drowsiness and slower reactions, especially with inhaled use
  • Calming supplements (valerian, melatonin): Caution (theoretical): additive sedation or relaxation
  • Blood-pressure-lowering supplements (garlic, magnesium): Monitor (theoretical): additive blood pressure lowering with inhaled lavender
  • Tea tree oil and other topical essential oils: Caution (theoretical): hormone-like effects in children with combined topical use; added allergen load
  • Topical ketoprofen with sun exposure: Caution (theoretical): sun-triggered allergic skin rash
    •

Risk & Side Effects

  • High:
  • Medium: Belching and digestive complaints with oral use
    •
  • Low: Reduced alertness and working memory with inhalation; allergic and photoallergic skin reactions; hormone-like effects and breast growth in children; poisoning from ingesting retail oil
    •
  • Speculative: Bleeding tendency; skin-cell and nerve toxicity at high concentrations
    •

Monitoring

Marker Target Why
GAD-7 anxiety score No established target; track change from own baseline Main anxiety outcome
PSQI sleep score No established target; track change from own baseline Sleep quality
Resting blood pressure No established target; track change from own baseline and readings below 90/60 mm Hg Safety check: additive lowering with blood-pressure drugs
Skin patch test with diluted oil No established target; track any redness, itching or blistering at 48 hours Safety check: a positive reaction stops topical use

Cadence: Baseline before starting; questionnaires repeated at 2, 6 and 10 weeks, then every 3 months during continued use; blood pressure weekly for the first month when antihypertensives are taken; 48-hour patch test before topical use

Qualitative Assessment

  • Daytime calm, worry and tension
  • Ease of falling asleep and morning restedness
  • Belching or indigestion after capsules
  • Skin redness or itching after topical use
  • Alertness and reaction speed after inhalation
  • In children exposed to topical products: any new breast tissue
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.